You are here
Consultations
We conduct public consultations as part of our broader stakeholder engagement work, including on changes to regulatory requirements or practices, reviews of business processes, standards or guidelines, and TGA fees and charges.
Filters
Status
Categories
- Advertising (9) Apply Advertising filter
- Australian Register of Therapeutic Goods (ARTG) (1) Apply Australian Register of Therapeutic Goods (ARTG) filter
- Biologicals (9) Apply Biologicals filter
- Blood and blood components (4) Apply Blood and blood components filter
- Complementary medicines (27) Apply Complementary medicines filter
- Cosmetics (2) Apply Cosmetics filter
- Disinfectants/Sterilants (4) Apply Disinfectants/Sterilants filter
- Import/Export (1) Apply Import/Export filter
- Labelling/Packaging (23) Apply Labelling/Packaging filter
- Legislation (23) Apply Legislation filter
- Listed medicines (3) Apply Listed medicines filter
- Remove Manufacturing filter Manufacturing (12)
- Medical devices safety (1) Apply Medical devices safety filter
- Medical devices/IVDs (53) Apply Medical devices/IVDs filter
- Remove Medicinal cannabis filter Medicinal cannabis (2)
- Medicines (1) Apply Medicines filter
- OTC medicines (40) Apply OTC medicines filter
- Other therapeutic goods (1) Apply Other therapeutic goods filter
- Prescription medicines (28) Apply Prescription medicines filter
- Safety of medicines & medical devices (2) Apply Safety of medicines & medical devices filter
- Scheduling (46) Apply Scheduling filter
- Therapeutic Goods Administration (TGA) (7) Apply Therapeutic Goods Administration (TGA) filter
- Therapeutic goods regulation (6) Apply Therapeutic goods regulation filter
Potential reforms to medicinal cannabis manufacturing, labelling and packing requirement
Closed on 29 January 2021
Compounded medicines and good manufacturing practice (GMP)
Closed on 18 December 2020
Good Clinical Practice Inspections Program
Closed on 22 February 2019
Proposal to change the current good manufacturing practice (GMP) fees and charges
Closed on 5 March 2018
Therapeutic Goods Order No. 93 (Standard for Medicinal Cannabis)
Closed on 16 January 2017
TGA guidance on release for supply for medicines manufacturers
Closed on 6 September 2013
Proposal for automatic adoption of new versions of the PIC/S Guide to Good Manufacturing Practice for Medicinal Products
Closed on 12 August 2013
Options for reform of the regulatory framework for pharmacy compounding
Closed on 26 July 2013
Draft Australian regulatory guidelines for GMP clearance for overseas manufacturers
Closed on 15 November 2010
Seeking information from compounding pharmacies
Closed on 30 July 2010